# The Quietude Study: Quetiapine Use for Agitated Depression

> **NCT01363310** · PHASE3 · TERMINATED · sponsor: **Physicians Research And Education Network** · enrollment: 250 (estimated)

## Conditions studied

- Depression With Prominent Agitation

## Interventions

- **DRUG:** Quetiapine XR
- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT01363310
- **Lead sponsor:** Physicians Research And Education Network
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-02
- **Target enrollment:** 250 (ESTIMATED)
- **Why stopped:** Termination of sponsorship
- **Last updated:** 2014-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01363310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01363310, "The Quietude Study: Quetiapine Use for Agitated Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01363310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*